发明名称 PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHYSICAL FORM OF N-;4-;5-(CYCLOPENTYLOXYCARBONYL)AMINO-1-METHILINDOL-3-IL-METHYL-3- -METHOXYBENZOIL
摘要 FIELD: medicine, pharmacology. SUBSTANCE: method deals with pharmaceutical composition that contains N-[4-[5-(cyclopentyloxycarbonyl) amino-1-methylindol-3-il-methyl] -3-methoxybenzoil] -2-methylbenzolsulfonamide, polyvinylpyrrolidone and carrier at a certain weight ratio. The given composition is obtained by mixing and drying its ingredients. Physical form of active substance is characterized by an intake maximum at 1690, 1530, 1490, 1420, 1155, 1060, 862 and 550 cmcm . The given composition is considered to be an antagonist of leukotriens, it is stable and possesses high pharmaceutical activity. EFFECT: higher efficiency. 5 cl, 7 cl, 3 tbl
申请公布号 RU2106140(C1) 申请公布日期 1998.03.10
申请号 SU19915010340 申请日期 1991.12.11
申请人 ZENEKA LIMITED 发明人 DZHEJMS DZHOZEF KHOLOKHAN;IEUAN DZHON EHDVRDS;ROBERT DZHOZEF TIMKO;REHNDI DZHON BREHDVEHJ;ARLIN KLEMENTS;DZHEJMS DZHOZEF KHOLOKHAN;IEUAN DZHON EHDVRDS;ROBERT DZHOZEF TIMKO;REHNDI DZHON BREHDVEHJ;ARLIN KLEMENTS
分类号 A61K31/18;A61K9/00;A61K9/16;A61K9/20;A61K31/166;A61K31/40;A61K31/403;A61K31/404;A61K47/26;A61K47/32;A61K47/38;A61P9/00;A61P11/00;A61P11/06;A61P17/00;A61P29/00;A61P35/00;A61P37/08;C07C307/02;C07D209/10;C07D209/18;C07D209/24;C07D209/30;C07D209/40 主分类号 A61K31/18
代理机构 代理人
主权项
地址